Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
KISS1 Receptor Research Peptide — Nasal Spray
Kisspeptin-10 is a synthetic decapeptide derived from the larger KISS1 peptide sequence. It is developed for controlled laboratory research involving KISS1 receptor (GPR54) signaling systems.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Kisspeptin-10 is a synthetic decapeptide derived from the larger KISS1 peptide sequence. It is developed for controlled laboratory research involving KISS1 receptor (GPR54) signaling systems.
In scientific literature, kisspeptin-10 is studied in experimental models examining hypothalamic-pituitary signaling pathways, reproductive axis regulation frameworks, and receptor-mediated endocrine signaling under in vitro and preclinical research conditions.
Kisspeptin-10 represents the biologically active C-terminal fragment of the KISS1 peptide and has been evaluated in research focused on KISS1 receptor interaction and neuroendocrine signaling systems. Experimental studies examine receptor binding dynamics and downstream signaling mechanisms within controlled laboratory environments.
Research publications have explored its interaction with hypothalamic signaling pathways and reproductive regulatory frameworks under preclinical and clinical research conditions.
The KISS1 gene was originally identified in oncology research before its role in neuroendocrine signaling was characterized. Subsequent investigations demonstrated the interaction of kisspeptins with the GPR54 (KISS1R) receptor, leading to expanded research into reproductive and hypothalamic signaling pathways.
Kisspeptin-10 became a commonly studied fragment due to its receptor activity profile in controlled experimental systems.
Laboratory investigations into kisspeptin-10 have focused on KISS1 receptor activation models and neuroendocrine signaling pathways. Research frameworks evaluate receptor-mediated interaction, hypothalamic signaling systems, and endocrine regulatory mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 12mg of lyophilized kisspeptin-10. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the lyophilized peptide. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab 96(12):E1963–E1972.
PubMedCentral and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 16(10):850–858.
PubMedKisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells.
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$80.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
